Blog

Categories
  1. Rezdiffra and Weight Loss Medicines: Rivals or Partners in Treating MASH?

    Can Rezdiffra lead to weight loss and how can it be combined with weight loss medicines as part of your MASH treatment?

    Read more »
  2. What patients should know about ensifentrine, the newest medication for COPD

    All you should know about the newest treatment for COPD, including how it compares to other medicines.

    Read more »
  3. Resmetirom's approval in Europe and the UK: When will the MASH medicine be available?

    When will the first approved medicine for fatty liver with fibrosis be available in Europe and the UK?

    Read more »
  4. Ensifentrine's EMA approval: When will the newest inhaled COPD medicine be available in Europe?

    When will the new medicine for COPD be available to patients in Europe and the UK (and how not to wait)?

    Read more »
  5. Zolbetuximab for pancreatic cancer: Is approval expected soon?

    What are the latest clinical trial results for zolbetuximab in pancreatic cancer, and is approval expected soon?

    Read more »
  6. After zolbetuximab's EU approval: When will the medicine be available to patients?

    When will the first targeted therapy for CLDN 18.2-positive gastric and GEJ cancer be available to patients in Europe?

    Read more »
  7. Watch for the glimmer in his eyes: The story of Helene and her father

    The story of a daughter navigating her father's Alzheimer's diagnosis and the transformations it brought.

    Read more »
  8. Finding meaning in the small things: The story of Kees and his mother

    The story of a son dealing with his mother's Alzheimer's diagnosis over the course of 15 years.

    Read more »
  9. Revumenib’s approval in Europe and beyond: When is the breakthrough treatment for leukemia coming to you?

    When will the first targeted therapy for acute leukemia with KMT2A translocation be available outside the USA?

    Read more »
  10. Miplyffa’s approval: How long until the first medicine for Niemann-Pick is available in your country?

    When will the first medicine for NPC be available to patients in Europe, the UK, and beyond (and how not to wait)?

    Read more »
  11. Ibudilast for ALS: When is FDA approval coming (and how not to wait)?

    When is Ketas (ibudilast) expected to be approved in the USA, EU, and more? And how can you start your ALS treatment in the meantime?

    Read more »
  12. Strength in Every Step: A Conversation with Michael Cramer

    An interview with cancer survivor and health advocate Michael Cramer about the challenges of staying positive, and how to remain empowered as a patient.

    Read more »
  13. Zanidatamab’s Approval for Biliary Tract Cancer: How Long Will You Have to Wait?

    When is the first targeted therapy for HER2-expressing BTC getting its approval? All about the timelines and your options in the meantime.

    Read more »
  14. Upcoming Alzheimer’s Medicines Currently in Development

    What are the current directions of Alzheimer's medicine research, and which medicines are promising?

    Read more »
  15. Remember There's More: Exploring New Options in Alzheimer's Treatment with Dr. Niels Prins

    An interview with Dr. Niels Prins from the Brain Research Center in Amsterdam about the future of Alzheimer's treatment.

    Read more »
  16. How to Participate in Alzheimer's Clinical Trials in The Netherlands

    How to find and participate in clinical trials in the Netherlands, as a way to support treatment development and access medicines not yet available locally.

    Read more »
  17. How can you test if you have Alzheimer’s in the Netherlands?

    How is Alzheimer's diagnosed in the Netherlands, what tests are required, and where to get started? All you need to know.

    Read more »
  18. Essential Alzheimer's Medicines to Begin at Diagnosis for Optimal Results

    Which medicines might your doctor prescribe for the early stages of Alzheimer's? Check all your options in and outside the Netherlands.

    Read more »
  19. A Small but Meaningful Chance: How One Family's Donation Gave Us Hope for Treatment

    How a patient from Russia received hope through another family's medicine donation.

    Read more »
  20. Getting the Right Tests Can Make All the Difference: A Brother’s Journey to Find Hope Beyond Borders

    A patient in Venezuela shares his journey of getting cancer medicines unavailable in the country.

    Read more »
  21. Is there a new medicine against Alzheimer’s [2024]?

    What are the newest medicines for Alzheimer's disease in Europe and the world?

    Read more »
  22. Can I take Leqembi together with Eliquis?

    Read more »
  23. How can you slow down Alzheimer’s disease? Some approaches to try.

    Which medicines and lifestyle changes can help slow down cognitive decline in Alzheimer's patients?

    Read more »
  24. Alzheimer’s treatments in the Netherlands: What is (not yet) available? [2024]

    Which medicines for Alzheimer's are available to Dutch patients (and which - not yet)?

    Read more »
  25. Kisqali for early breast cancer: Where is it available and how to get it now?

    Where is Kisqali (ribociclib) approved as an adjuvant treatment for early breast cancer (and how to get it if it's not yet in your country)?

    Read more »
  26. Nipocalimab's approval: When is the latest treatment for myasthenia gravis coming to you?

    When is the latest treatment for myasthenia gravis going to be available to patients around the world?

    Read more »
  27. Opzelura cream in India: How to get the new vitiligo treatment?

    How to get the new vitiligo ointment from a trusted supplier in India?

    Read more »
  28. Vimseltinib's approval worldwide: When is the new TGCT treatment coming to you?

    When is the new treatment for TGCT expected to get approval, and how long will you have to wait?

    Read more »
  29. Mirdametinib's approval worldwide: When is the new NF1 treatment coming to you?

    When is the new treatment for NF1 expected to get approval worldwide? Find out all you need to know about mirdametinib.

    Read more »
  30. Inavolisib for breast cancer: When is approval coming (from the FDA, EMA, and more)?

    When is the newest treatment for HR-positive, HER2-negative breast cancer expected to get FDA, EMA, MHRA approval, and more?

    Read more »
Page
US United States 0